Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma (MATRix)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02531841
Recruitment Status : Unknown
Verified August 2015 by Elisabeth Schorb, University Hospital Freiburg.
Recruitment status was:  Recruiting
First Posted : August 25, 2015
Last Update Posted : August 25, 2015
Sponsor:
Collaborators:
German Federal Ministry of Education and Research
International Extranodal Lymphoma Study Group (IELSG)
Information provided by (Responsible Party):
Elisabeth Schorb, University Hospital Freiburg

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 2017
Estimated Study Completion Date : December 2019
Publications of Results:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):